Literature DB >> 14755341

Defects in secretion, aggregation, and thrombus formation in platelets from mice lacking Akt2.

Donna Woulfe1, Hong Jiang, Alicia Morgans, Robert Monks, Morris Birnbaum, Lawrence F Brass.   

Abstract

Prior studies have shown that PI3Ks play a necessary but incompletely defined role in platelet activation. One potential effector for PI3K is the serine/threonine kinase, Akt, whose contribution to platelet activation was explored here. Two isoforms of Akt were detected in mouse platelets, with expression of Akt2 being greater than Akt1. Deletion of the gene encoding Akt2 impaired platelet aggregation, fibrinogen binding, and granule secretion, especially in response to low concentrations of agonists that activate the G(q)-coupled receptors for thrombin and thromboxane A(2). Loss of Akt2 also impaired arterial thrombus formation and stability in vivo, despite having little effect on platelet responses to collagen and ADP. In contrast, reducing Akt1 expression had no effect except when Akt2 was also deleted. Activation of Akt by thrombin was abolished by deletion of Galpha(q) but was relatively unaffected by deletion of Galpha(i2), which abolished Akt activation by ADP. From these results we conclude that Akt2 is a necessary component of PI3K-dependent signaling downstream of G(q)-coupled receptors, promoting thrombus growth and stability in part by supporting secretion. The contribution of Akt1 is less evident except in the setting in which Akt2 is absent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14755341      PMCID: PMC324545          DOI: 10.1172/JCI20267

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  37 in total

1.  Potentiation of thromboxane A2-induced platelet secretion by Gi signaling through the phosphoinositide-3 kinase pathway.

Authors:  C Dangelmaier; J Jin; J B Smith; S P Kunapuli
Journal:  Thromb Haemost       Date:  2001-02       Impact factor: 5.249

2.  A key role of adenosine diphosphate in the irreversible platelet aggregation induced by the PAR1-activating peptide through the late activation of phosphoinositide 3-kinase.

Authors:  C Trumel; B Payrastre; M Plantavid; B Hechler; C Viala; P Presek; E A Martinson; J P Cazenave; H Chap; C Gachet
Journal:  Blood       Date:  1999-12-15       Impact factor: 22.113

3.  Phosphoinositide 3-kinase gamma and p85/phosphoinositide 3-kinase in platelets. Relative activation by thrombin receptor or beta-phorbol myristate acetate and roles in promoting the ligand-binding function of alphaIIbbeta3 integrin.

Authors:  J Zhang; J Zhang; S J Shattil; M C Cunningham; S E Rittenhouse
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

4.  The central role of the P(2T) receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity.

Authors:  R F Storey; H M Sanderson; A E White; J A May; K E Cameron; S Heptinstall
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

5.  Identification of the platelet ADP receptor targeted by antithrombotic drugs.

Authors:  G Hollopeter; H M Jantzen; D Vincent; G Li; L England; V Ramakrishnan; R B Yang; P Nurden; A Nurden; D Julius; P B Conley
Journal:  Nature       Date:  2001-01-11       Impact factor: 49.962

6.  Impaired activation of murine platelets lacking G alpha(i2).

Authors:  H M Jantzen; D S Milstone; L Gousset; P B Conley; R M Mortensen
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

7.  Resistance to thromboembolism in PI3Kgamma-deficient mice.

Authors:  E Hirsch; O Bosco; P Tropel; M Laffargue; R Calvez; F Altruda; M Wymann; G Montrucchio
Journal:  FASEB J       Date:  2001-07-09       Impact factor: 5.191

8.  Akt1/PKBalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice.

Authors:  H Cho; J L Thorvaldsen; Q Chu; F Feng; M J Birnbaum
Journal:  J Biol Chem       Date:  2001-08-31       Impact factor: 5.157

9.  Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta).

Authors:  H Cho; J Mu; J K Kim; J L Thorvaldsen; Q Chu; E B Crenshaw; K H Kaestner; M S Bartolomei; G I Shulman; M J Birnbaum
Journal:  Science       Date:  2001-06-01       Impact factor: 47.728

10.  Desensitization of the platelet aggregation response to ADP: differential down-regulation of the P2Y1 and P2cyc receptors.

Authors:  A Baurand; A Eckly; N Bari; C Léon; B Hechler; J P Cazenave; C Gachet
Journal:  Thromb Haemost       Date:  2000-09       Impact factor: 5.249

View more
  85 in total

1.  A G(i) -independent mechanism mediating Akt phosphorylation in platelets.

Authors:  B Xiang; G Zhang; J Liu; A J Morris; S S Smyth; T K Gartner; Z Li
Journal:  J Thromb Haemost       Date:  2010-09       Impact factor: 5.824

2.  Arrestin-2 differentially regulates PAR4 and ADP receptor signaling in platelets.

Authors:  Dongjun Li; Lauren D'Angelo; Massiel Chavez; Donna S Woulfe
Journal:  J Biol Chem       Date:  2010-11-24       Impact factor: 5.157

Review 3.  Signaling during platelet adhesion and activation.

Authors:  Zhenyu Li; M Keegan Delaney; Kelly A O'Brien; Xiaoping Du
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-11-11       Impact factor: 8.311

4.  AKT2 regulates endothelial-mediated coagulation homeostasis and promotes intrathrombotic recanalization and thrombus resolution in a mouse model of venous thrombosis.

Authors:  Wanmu Xie; Lin Zhang; Wei Luo; Zhenguo Zhai; Chen Wang; Ying H Shen
Journal:  J Thromb Thrombolysis       Date:  2020-07       Impact factor: 2.300

5.  A novel STAT3 inhibitor negatively modulates platelet activation and aggregation.

Authors:  Zhuan Xu; Yu-Jia Xu; Ya-Nan Hao; Li-Jie Ren; Zu-Bin Zhang; Xin Xu; Bi-Yin Cao; Ke-Sheng Dai; Li Zhu; Qi Fang; Yan Kong; Xin-Liang Mao
Journal:  Acta Pharmacol Sin       Date:  2017-03-06       Impact factor: 6.150

6.  Irreversible platelet activation requires protease-activated receptor 1-mediated signaling to phosphatidylinositol phosphates.

Authors:  Michael Holinstat; Anita M Preininger; Stephen B Milne; W James Hudson; H Alex Brown; Heidi E Hamm
Journal:  Mol Pharmacol       Date:  2009-05-29       Impact factor: 4.436

7.  Akt signaling in platelets and thrombosis.

Authors:  Donna S Woulfe
Journal:  Expert Rev Hematol       Date:  2010-02       Impact factor: 2.929

8.  Role of phosphoinositide 3-kinase beta in glycoprotein VI-mediated Akt activation in platelets.

Authors:  Soochong Kim; Pierre Mangin; Carol Dangelmaier; Rivka Lillian; Shaun P Jackson; James L Daniel; Satya P Kunapuli
Journal:  J Biol Chem       Date:  2009-08-21       Impact factor: 5.157

9.  Hematopoietic lineage cell specific protein 1 (HS1) is a functionally important signaling molecule in platelet activation.

Authors:  Bryan N Kahner; Robert T Dorsam; Sripal R Mada; Soochong Kim; Timothy J Stalker; Lawrence F Brass; James L Daniel; Daisuke Kitamura; Satya P Kunapuli
Journal:  Blood       Date:  2007-06-19       Impact factor: 22.113

10.  Insulin-like growth factor-1 regulates platelet activation through PI3-Kalpha isoform.

Authors:  Soochong Kim; Analia Garcia; Shaun P Jackson; Satya P Kunapuli
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.